Home›Companies›Biotech & Pharma›SirnaMed Therapeutics

SirnaMed Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 25, 2024·Suggest an edit

About SirnaMed Therapeutics

SirnaMed Therapeutics is a private company based in Sewickley, Pennsylvania, incorporated in 2023 in Delaware. It has reported $1,250,000 raised in one offering on Form D since July 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 10, 2024Jul 25, 2024$1,250,000of $1.5M target9$138KOptions, Securities on exercise, Simple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SirnaMed Therapeutics's Form D filed Jul 25, 2024.

PT
Phong Tran
Executive officer
Stanley Marks
Stanley Marks
Director
Also a board chairman at Duo Oncology.
JH
Jing-Zhou Hou
Treasurer and director
Also a co-founder and director at Duo Oncology.
SL
Song Li
Executive officer, director and promoter
Also a co-founder and director at Duo Oncology.

Sources

  1. SECSirnaMed Therapeutics Inc. filing history